Yogen Saunthararajah

机构：Cleveland Clinic, Case Western Reserve University · ORCID：0000-0002-9757-1031

发表论文 384 篇 · 总被引 10848 次 · h-index 53

代表论文

A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML (2023 · Clinical Cancer Research · 被引 18)
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort (2024 · Blood · 被引 17)
Pharmacokinetics and pharmacodynamics of an oral formulation of decitabine and tetrahydrouridine (2023 · European Journal Of Haematology · 被引 13)
DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway (2023 · Cancers · 被引 10)
Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy (2023 · Cell Reports · 被引 9)
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies (2024 · Cytometry Part B Clinical Cytometry · 被引 4)